ZIVO Bioscience, Inc. (ZIVO)

Market Cap	28.23M -45.6%
Revenue (ttm)	209.03K +164.5%
Net Income	-8.49M
EPS	-2.27
Shares Out	4.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	216
Open	6.50
Previous Close	6.50
Day's Range	6.50 - 6.80
52-Week Range	1.11 - 17.50
Beta	0.39
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About ZIVO Bioscience

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and ani...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1983
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: ZIVO

Financial Performance

In 2024, ZIVO Bioscience's revenue was $157,220, an increase of 468.61% compared to the previous year's $27,650. Losses were -$13.38 million, 72.1% more than in 2023.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 20, 2026

Data Sources Report a data error